Viewing Study NCT04150757


Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2026-02-13 @ 8:49 AM
Study NCT ID: NCT04150757
Status: TERMINATED
Last Update Posted: 2024-11-18
First Post: 2019-10-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED
Sponsor: Abigail Nixon
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sickle Cell Disease View
None Vaso-Occlusive Pain Episode in Sickle Cell Disease View
None Vaso-occlusive Crisis View
None Ketamine View
None Intranasal Ketamine View
None Analgesia View
Keywords: